NOVEL TRICYCLIC COMPOUNDS

The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The comp...

Full description

Saved in:
Bibliographic Details
Main Authors DAWN M. GEORGE, BRYAN A. FIAMENGO, NEIL WISHART, DAVID J. CALDERWOOD, ERIC C. BREINLINGER, LU WANG, MICHAEL FRIEDMAN, ANNA M. ERICSSON, KELLY D. MULLEN, JEFFREY W. VOSS, ERIC R. GOEDKEN, GRIER A. WALLACE, GAGANDEEP SOMAL, MARIA A. ARGIRIADI, KENT D. STEWART, BIQIN C. LI, KRISTINE E. FRANK, NATHAN S. JOSEPHSOHN, MICHAEL J. MORYTKO, KEVIN R. WOLLER
Format Patent
LanguageEnglish
Spanish
Published 19.06.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. La invención proporciona un compuesto de Fórmula (la), (Ib), (Ic), (Id), (le), (If), (lg), (Ih), (Ii), (lj), (1k), o (II) como se define en la presente, sales farmacéuticamente aceptables, profármacos, metabilitos biológicamente activos, estereoisómeros e isómeros de los mismos en donde las variables son como se define en la presente. Los compuestos de la invención son útiles para tratar condiciones inmunológicas y oncológicas.
Bibliography:Application Number: MX20120006381